IL17A and arthritic joint disease: Reduces arthritis clinical score, and pro-inflammatory cytokine levels (TNF-α, IL-β, IL-6, IFN-γ, IL-17A). Increases levels of IL-10, TGF-β, and miR-21. Regulates Treg/Th17 balance.